Literature DB >> 27777091

Clinical metagenomic analysis of bacterial communities in breast abscesses of granulomatous mastitis.

Hai-Jing Yu1, Hua Deng2, Jian Ma2, Shu-Jun Huang2, Jian-Min Yang1, Yan-Fen Huang3, Xiao-Ping Mu3, Liang Zhang4, Qi Wang5.   

Abstract

BACKGROUND: Granulomatous mastitis (GM) is a chronic inflammatory breast lesion. Its etiology remains incompletely defined. Although mounting evidence suggests the involvement of Corynebacterium in GM, there has been no systematic study of GM bacteriology using -omics technology.
METHODS: The bacterial diversity and relative abundances in breast abscesses from 19 women with GM were investigated using 16S rDNA metagenomic sequencing and Sanger sequencing. A quantitative PCR (qPCR) assay was also developed to identify Corynebacterium kroppenstedtii.
RESULTS: A bioinformatic analysis revealed that Corynebacterium was present in the 19 GM patients, with abundances ranging from 1.1% to 58.9%. Of note, Corynebacterium was the most abundant taxon in seven patients (more than a third of the subjects). The predominance of Corynebacterium kroppenstedtii infection (11 of 19 patients, 57.9%) was confirmed with Sanger sequencing and the qPCR assay.
CONCLUSIONS: This study profiled the microbiota of patients with GM and indicated an important role for Corynebacterium, and in particular C. kroppenstedtii, in the pathogenesis of this disease.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  C. kroppenstedtii; Corynebacterium; Granulomatous mastitis; Metagenomic sequencing; Microbiota

Mesh:

Substances:

Year:  2016        PMID: 27777091     DOI: 10.1016/j.ijid.2016.10.015

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

1.  Societal Implications of the Internet of Pathogens.

Authors:  Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  Pathogen determination from clinical abscess fluids using metagenomic next-generation sequencing.

Authors:  Yuxi Zhao; Jinlian Chen; Bing Bai; Yu Wang; Jinxin Zheng; Zhijian Yu; Qiwen Deng; Peiyu Li
Journal:  Folia Microbiol (Praha)       Date:  2020-11-02       Impact factor: 2.099

3.  Role of Bacteriological Agents in Idiopathic Granulomatous Mastitis: Real or Not?

Authors:  Taner Kıvılcım; Fatih Altıntoprak; Bahar Memiş; Murat Ferhat Ferhatoğlu; Abdulcabbar Kartal; Enis Dikicier; İhsan Hakkı Ciftçi; Fatma Hüsniye Dilek
Journal:  Eur J Breast Health       Date:  2018-11-05

4.  Granulomatous Lobular Mastitis Associated with Mycobacterium abscessus in South China: A Case Report and Review of the Literature.

Authors:  Ye-Sheng Wang; Qi-Wei Li; Lin Zhou; Run-Feng Guan; Xiang-Ming Zhou; Ji-Hong Wu; Nan-Yan Rao; Shuang Zhu
Journal:  Case Rep Infect Dis       Date:  2017-02-12

5.  Differential expression profiles of miRNA in granulomatous lobular mastitis and identification of possible biomarkers.

Authors:  Jie Ling; Xianmin Xie; Yue Wang; Weifang Huang; Jun Luo; Jingqun Su; Hongqiao Fan; Shiting Wu; Lifang Liu
Journal:  Exp Ther Med       Date:  2022-06-08       Impact factor: 2.751

6.  Clinical study on surgical treatment of granulomatous lobular mastitis.

Authors:  Chaojie Zhang; Shanshan Lei; Cheng Kong; Yuanzhen Tan; Xu Dai; Jie He; Qiang Xiao; Shulin Huang
Journal:  Gland Surg       Date:  2019-12

7.  Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication.

Authors:  Sally C Y Wong; Rosana W S Poon; Jonathan H K Chen; Herman Tse; Janice Y C Lo; Tak-Keung Ng; Jonathan C K Au; Cindy W S Tse; Ingrid Y Y Cheung; Man-Ting Yuk; Wei-Kwang Luk; Kwok-Yung Yuen
Journal:  Open Forum Infect Dis       Date:  2017-05-06       Impact factor: 3.835

8.  Minimally invasive comprehensive treatment for granulomatous lobular mastitis.

Authors:  Yaohuai Wang; Junlong Song; Yi Tu; Chuang Chen; Shengrong Sun
Journal:  BMC Surg       Date:  2020-02-22       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.